Table 2.
Clinical Factors | PARP-1 Low Expression (0–3) |
PARP-1 High Expression (4–12) |
p-value |
---|---|---|---|
Gender | |||
Male | 9 | 27 | 0.033 |
Female | 26 | 29 | |
Age | |||
≤ 63 | 20 | 23 | 0.135 |
> 63 | 15 | 33 | |
Ciliary body involvement | |||
No | 24 | 30 | 0.156 |
Yes | 11 | 26 | |
Iris involvement | |||
No | 33 | 51 | 0.576 |
Yes | 2 | 5 | |
Irido-corneal angle involvement | |||
No | 1 | 6 | 0.171 |
Yes | 34 | 50 | |
Intrascleral extension | |||
No | 1 | 12 | 0.014 |
Yes | 34 | 44 | |
Extrascleral extension | |||
No | 32 | 49 | 0.560 |
Yes | 3 | 7 | |
Tumor size | |||
≤15 mm | 25 | 30 | 0.079 |
>15 mm | 10 | 26 | |
Mitoses | |||
≤4 | 25 | 31 | 0.126 |
>4 | 10 | 23 | |
Grade | |||
G1 + G2 | 32 | 40 | 0.022 |
G3 | 3 | 16 | |
Chromosome 3 loss | |||
No | 11 | 5 | 0.008 |
Yes | 16 | 35 | |
Metastases | |||
No | 19 | 28 | 0.691 |
Yes | 16 | 28 |